1,https://www.taihooncology.com/us/
2,https://www.taihooncology.com/
3,https://www.otsuka.com/en/ir/
4,https://www.taihooncology.com/us/science/partnering/
5,https://www.taihooncology.com/us/contact/
6,https://www.taihooncology.com/us/about/
7,https://www.taihooncology.com/us/about/leadership-team/
8,https://www.taihooncology.com/us/about/social-responsibility/
9,https://www.taihooncology.com/us/science/
10,https://www.taihooncology.com/us/science/research-development/
11,https://www.taihooncology.com/us/science/product-pipeline/
12,https://www.taihooncology.com/us/science/investigator-initiated-trials/
13,https://www.taihooncology.com/us/science/expanded-access/
14,https://www.taihooncology.com/us/products/
15,https://www.taihooncology.com/us/products/medical-information/
16,https://www.taihooncology.com/us/grants-donations/
17,https://www.taihooncology.com/us/grants-donations/continuing-medical-education/
18,https://www.taihooncology.com/us/grants-donations/charitable-contributions/
19,https://www.taihooncology.com/us/careers/
20,https://www.taihooncology.com/us/careers/corporate-culture/
21,https://www.taihooncology.com/us/careers/employee-benefits/
22,https://www.taihooncology.com/us/careers/job-postings/
23,https://www.taihooncology.com/us/news/
24,https://www.taihooncology.com/us/news/2021-11-01_stomach_cancer_awareness_month_press_release/
25,https://www.taihooncology.com/us/news/2021-09-23_astex_press_release_astx727_mos_data_presented_at_mds_international_symposium/
26,https://www.taihooncology.com/us/news/2021-09-13_toi_esmo_2021_curtain_raiser/
27,https://www.taihooncology.com/us/privacy/
28,https://www.taihooncology.com/us/terms/
29,https://taihocorp-media-release.s3.us-west-2.amazonaws.com/documents/Declaration_of_Compliance_for_California_2019.pdf
30,https://taihocorp-media-release.s3.us-west-2.amazonaws.com/documents/vermont-short-form.pdf
31,https://taihocorp-media-release.s3.us-west-2.amazonaws.com/documents/vermont-long-form.pdf
32,https://taihocorp-media-release.s3.us-west-2.amazonaws.com/documents/Tax_strategy_report.pdf
33,https://www.taihooncology.com/us/authorized-distributors/
34,https://www.taiho.co.jp/en/
35,http://www.otsuka.com/en/
36,https://debbiesdream.org/
37,https://gastriccancer.org/
38,https://www.gicancersalliance.org/
39,https://stocan.org/
40,https://nostomachforcancer.org/
41,https://www.theraymondfoundation.org/
42,https://www.gicancersalliance.org/wp-content/uploads/2020/10/Gastric-Cancer-Nutrition-Brochure_web.pdf
43,http://www.taihooncology.com
44,https://seer.cancer.gov/statfacts/html/stomach.html
45,https://www.taihooncology.com/documents/115/TOI-PM-US-0467_Stomach_Cancer_Awareness_Month_Press_Release_FINAL_10.28.21.pdf
46,http://www.otsuka.com/en
47,https://www.taihooncology.com/documents/103/Taiho_IIT_Application.V4-29JUN2021.pdf
48,http://rms.taihooncology.com/
49,https://www.taihomedicalinformation.com/
50,https://www.taihooncology.com/documents/87/request-for-proposal_-RMS_URL.pdf
51,https://www.taihooncology.com/us/news/2021-09-01_open_letter_from_taiho_oncology_on_blood_cancer_awareness_month/
52,https://www.taihooncology.com/us/news/2021-04-14_nccnorp_taiho_decitabinecedazuridineprojects/
53,http://www.nccn.org/
54,https://www.nccn.org/clinical_trials/clinicians.aspx
55,https://www.taihooncology.com/us/news/2021-04-11_aacr_2021_data_release/
56,https://www.taihooncology.com/us/news/2021-04-02_aacr_2021_curtain_raiser_release/
57,https://www.taihooncology.com/us/news/2021-04-01_toi_tpc_futibatinib_btd/
58,https://www.taihooncology.com/us/news/2021-03-01_toi_ccam_2021/
59,https://www.taihooncology.com/us/news/2021-02-04_toi_lonsurf_nccn_compendium/
60,https://www.taihooncology.com/us/news/2021-01-12_asco_gi_2021_curtain_raiser_release/
61,https://www.taihooncology.com/us/news/2020-12-09_toi_european_expansion/
62,https://www.taihooncology.com/us/news/2020-12-02_ash_2020_curtain_release/
63,https://www.taihooncology.com/us/news/2020-11-23_toi_inqovi_nccn_guidelines/
64,https://www.taihooncology.com/us/news/2020-11-02_gastric_cancer_awareness_month_2020/
65,https://www.taihooncology.com/us/news/2020-10-28_astex_press_release_nci_crada/
66,https://www.taihooncology.com/us/news/2020-10-23_mds_world_awareness_day/
67,https://www.taihooncology.com/us/news/2020-09-15_esmo_2020_curtain_release/
68,https://www.taihooncology.com/us/news/2020-09-08_astex_press_release_md_anderson_collaboration/
69,http://www.mdanderson.org/
70,https://www.taihooncology.com/us/news/2020-09-01-nccnorp-taiho-decitabine-cedazuridine/
71,https://www.taihooncology.com/us/news/2020-07-23-nccnorp-taiho-futibatinib/
72,http://www.nccn.org/orp
73,https://www.taihooncology.com/us/news/2020-07-dr_yoder_announcement/
74,https://www.taihooncology.com/us/news/2020-07-inqovi-approval/
75,https://www.taihooncology.com/us/news/2020-06-04-aacr-curtain-raiser-release/
76,https://www.taihooncology.com/us/news/2020-05-31-asco-2020-data-release/
77,https://www.taihooncology.com/us/news/2020-03-02-ccam-2020/
78,https://www.taihooncology.com/us/news/2020-02-11-astex-press-release-astx727-nda-acceptance/
79,https://www.taihooncology.com/us/news/2020-01-27-nccnorp-taiho-futibatinib/
80,https://www.nccn.org/members/network.aspx
81,https://www.taihooncology.com/us/news/2020-01-25-lonsurf-tas120-data-release-asco-gi-2020/
82,https://www.taihooncology.com/us/news/2019-10-31-toi-pm-us-0218-gcam-2019/
83,https://www.taihooncology.com/us/news/2019-10-10-lon-pm-us-1285-jama-oncology-data-press-release/
84,https://www.taihooncology.com/us/news/2019-06-06-pl-pm-us-0007-2019-toi-astex-commercialization/
85,https://www.taihooncology.com/us/news/2019-06-03-lon-pm-us-1265-2019-asco-data-release/
86,https://www.taihooncology.com/us/news/2019-03-14-nccn-awards-grants-investigators/
87,https://www.taihooncology.com/us/news/2019-03-01-toi-pm-us-0197-ccam-2019/
88,https://www.taihooncology.com/us/news/2019-02-25-lon-pm-us-1213-fda-approves-gastric/
89,https://www.taihooncology.com/us/news/2019-01-17-lon-pm-us-1152-toi-servier-present-data-asco-gi/
90,https://www.taihooncology.com/us/news/2018-10-25-lon-pm-us-1135-lonsurf-gastric-snda/
91,https://www.taihooncology.com/us/news/2018-10-22-nccn-awarded-2mill-research/
92,https://www.taihooncology.com/us/news/2018-10-21-lon-pm-us-1134-tags-esmo-2018-data-release/
93,https://www.taihooncology.com/us/news/2018-09-28-taiho-oncology-presents-real-world-adherence-data-lonsurf/
94,https://www.taihooncology.com/us/news/2018-06-21-lon-pm-us-1100-tags-esmo-gi-2018-data-release/
95,https://www.taihooncology.com/us/news/2018-06-20-taiho-oncology-presents-data-key-investigational-compound-tas-120/
96,https://www.taihooncology.com/us/news/2018-06-14-taiho-oncology-and-servier-present-data-lonsurf-esmo-2018/
97,https://www.taihooncology.com/us/news/2018-06-07-taiho-oncology-eliminates-co-pays-many-patients-treated-lonsurf/
98,https://www.taihooncology.com/us/news/2018-05-09-taiho-oncology-announces-positive-topline-results-pivotal-phase-3/
99,https://www.taihooncology.com/us/news/2018-04-13-taiho-oncology-presents-data-lonsurf/
100,https://www.taihooncology.com/us/news/2018-03-08-taiho-oncology-announces-support-awareness-research-initiatives/
101,https://www.taihooncology.com/us/news/2018-01-20-taiho-oncology-and-servier-present-lonsurf-data-asco-2018-gastrointestinal-cancers-symposium/
102,https://www.taihooncology.com/us/news/2018-01-19-otsuka-signs-statement-support-womens-empowerment-principles/
103,https://www.taihooncology.com/us/news/2018-01-12-taiho-oncology-announces-multiple-lonsurf-presentations-asco-2018/
104,https://www.taihooncology.com/us/news/2018-01-02-taiho_oncology_names_timothy_whitten_president/
105,https://www.taihooncology.com/us/news/2017-10-20-health-canada-grants-priority-review-status/
106,https://www.taihooncology.com/us/news/2017-10-04-taiho-pharmaceutical-participate-japan-healthcare-venture-summit-2017/
107,https://www.taihooncology.com/us/news/2016-11-18-taiho-oncology-inc-announces-expansion-canada/
108,https://www.taihooncology.com/us/news/2016-05-31-taiho-oncology-inc-multiple-presentations-asco-2016-annual-meeting/
109,https://www.taihooncology.com/us/news/2015-09-26-taiho-oncology-inc-announces-comprehensive-access-support-program-lonsurf/
110,https://www.taihooncology.com/us/news/2015-09-22-taiho-oncology-inc-announces-fda-approval-lonsurf-refractory-metastatic-colorectal-cancer/
111,https://www.taihooncology.com/us/news/2015-02-23-taiho-oncology-inc-announces-tas-102-new-drug-application-refractory-metastatic-colorectal-cancer-accepted-review-fda/
112,https://www.taihooncology.com/us/news/2014-12-22-taiho-oncology-completes-submission-tas-102-new-drug-application-us-food-and-drug-administration-treatment-refractory-metastatic-colorectal-cancer/
113,https://www.taihooncology.com/us/news/2014-10-20-taiho-oncology-inc-receives-fda-fast-track-designation-tas-102-potential-treatment-refractory-metastatic-colorectal-cancer/
114,https://www.taihooncology.com/us/news/2014-07-23-taiho-pharmaceutical-invests-us-30-million-remiges-biopharma-fund-lp-foster-early-biotech-start-ups/
115,https://www.taihooncology.com/us/news/2014-06-28-taiho-oncology-inc-announces-results-tas-102-global-phase-iii-recourse-trial-refractory-metastatic-colorectal-cancer/
116,https://www.taihooncology.com/us/news/2014-05-12-taiho-oncology-inc-marks-transition-commercial-entity-key-management-appointment/
117,https://lonsurf.com
118,https://taihocorp-media-release.s3.us-west-2.amazonaws.com/documents/prescribing-information.pdf
119,https://taihocorp-media-release.s3.us-west-2.amazonaws.com/documents/patient-information.pdf
120,https://WWW.INQOVI.COM
121,https://taihocorp-media-release.s3.us-west-2.amazonaws.com/documents/INQOVI_Prescribing_Information.pdf
122,https://taihocorp-media-release.s3.us-west-2.amazonaws.com/documents/INQOVI_Patient_Information.pdf
123,https://www.taihopatientsupport.com/
124,https://astx.com/wp-content/uploads/2021/09/2021_ASTX727_Poster_MDS-abst-P48_Savona_final.pdf
125,https://www.inqovi.com/
126,https://www.inqovi.com/pi
127,https://www.astx.com/
128,https://www.otsuka.co.jp/en/
129,http://www.inqovi.com/pi
130,https://www.cancer.org/cancer/chronic-myelomonocytic-leukemia/about/key-statistics.html
131,https://www.cancerresearchuk.org/about-cancer/other-conditions/chronic-myelomonocytic-leukaemia-cmml/about
132,https://www.taihooncology.com/documents/114/INQ-PM-US-0362_Astex_Press_Release_-_ASTX727_-_mOS_Data_Presented_at_MDS_International.pdf
133,http://clinicaltrials.gov
134,http://www.taiho.co.jp/english/rd/pipeline.html
135,https://www.taihooncology.com/us/science/product-pipeline/lonsurf/
136,https://www.taihooncology.com/us/science/product-pipeline/tas-117/
137,https://www.taihooncology.com/us/science/product-pipeline/tas3681/
138,https://www.taihooncology.com/us/science/product-pipeline/tas0612/
139,https://www.taihooncology.com/us/science/product-pipeline/tas2940/
140,http://www.ftc.gov/ogc/coppa1.htm
141,https://www.privacyshield.gov/
142,https://www.jamsadr.com/eu-us-privacy-shield
143,https://www.taihooncology.com/documents/5/Expanded_Access_Form_v2_Feb2020.pdf
144,https://www.taihooncology.com/documents/74/Futibatinib_Access_Form_03Feb2020_Final.pdf
145,https://clinicaltrials.gov/
146,https://www.fda.gov/NewsEvents/PublicHealthFocus/ExpandedAccessCompassionateUse/default.htm
147,http://www.taihooncology.ethicspoint.com
148,https://solutions.sciquest.com/apps/Router/SupplierLogin
149,https://cslide.ctimeetingtech.com/esmo2021/attendee/confcal_4/presentation/list
150,http://www.taihooncology.com/
151,https://www.taihooncology.com/documents/110/TOI-PM-US-0425_TOI_ESMO_2021_Curtain_Raiser_FINAL.pdf
152,https://www.taihopharma.ca/
153,https://www.taihooncology.eu/
154,http://www.taiho.com.sg/
155,http://www.taihochina.com/
156,https://www.taihoventures.com/
157,https://www.taihooncology.com/documents/111/NatureBioPharmDealmakersTaihoMAR2021-0622.pdf
158,https://www.taihooncology.com/documents/113/TOI-PM-US-0390_TOI_Non_Confidential_BD_Presentation_FINALR_09202021.pdf
